Primary hepatic neuroendocrine tumor after 4 years tumor-free follow-up

J Gastrointestin Liver Dis. 2015 Jun;24(2):241-4. doi: 10.15403/jgld.2014.1121.242.yrs.

Abstract

Background: A primary hepatic neuroendocrine tumour (PHNET) is a very rare disease. The liver represents the preferential site for neuroendocrine tumors' metastases.

Case presentation: A 45-year old Caucasian female who presented with nausea, vomiting, diarrhea, accompanied by diffuse abdominal pain was found to have on contrast-enhanced computer tomography an encapsulated, partially cystic liver mass. The patient underwent an uneventful left atypical hepatic resection. Histopatological and immunohistochemical examination revealed a slowly growing (G1) hepatic neuroendocrine tumour. Post surgery, the specific neuroendocrine markers (serum Chromogranin A and 24h urinary 5 hydroxy-indolacetic acid) were within normal range. Further functional imaging investigations were performed. No other lesions were found making probable the diagnosis of PHNET. The patient is presently after 4 years of follow-up with no local recurrence or distant metastases.

Conclusions: The diagnosis of PHNET is a medical challenge that requires a thorough long term follow-up in order to exclude an occult primary neuroendocrine tumour.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / analysis
  • Biopsy
  • Carcinoma, Neuroendocrine / chemistry
  • Carcinoma, Neuroendocrine / pathology
  • Carcinoma, Neuroendocrine / surgery*
  • Female
  • Hepatectomy*
  • Humans
  • Immunohistochemistry
  • Middle Aged
  • Multimodal Imaging / methods
  • Pancreatic Neoplasms / chemistry
  • Pancreatic Neoplasms / pathology
  • Pancreatic Neoplasms / surgery*
  • Positron-Emission Tomography
  • Predictive Value of Tests
  • Time Factors
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Biomarkers, Tumor